Track the Vicore Pharma Holding AB stock price and the full insider trade history of the company, a listed equity based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Vicore Pharma Holding AB has recorded 5 insider filings. Market capitalisation: €3.1bn. The latest transaction was disclosed on 8 July 2026 (Purchase). Among the most active insiders: Yasir Al-Wakeel. The full history is openly available.
5
Insider Decl.
n/a
Thresholds
€176,070
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Vicore Pharma Holding AB Strong Buy (bullish), based on 5 analysts. Average price target: SEK 31.40.
33Σ signal
Buys €176,070n/a Sells
Fundamental score
Ranked 22,473 of 29,062 companies
32.7
score / 100
Value
13
Quality
52
FCF yld-13%
Earn yld-16%
EV/EBITDA·
ROE-57%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,000 shares@ €0.70370.0002% mcap100.0% of flowAktieISINISIN SE0007577895FI:A003O165-1
5 of 5 declarations
Acerca de Vicore Pharma Holding AB
Vicore Pharma Holding AB es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades respiratorias. Cotiza en la Bolsa de Estocolmo (XSTO).